NexGenix Pharmaceuticals Employee Directory

Pharmaceutical ManufacturingUnited States2-10 Employees

NexGenix Pharmaceuticals is a privately held US-based drug discovery and development company that concentrates on targeted therapies for cancer and nervous-system disorders. It has built a platform anchored in resorcylic macrolide chemistry and inhibitors of the chaperone protein Hsp90, developed through in-licensing and research collaborations. The company's work is motivated by the view that misregulation of protein homeostasis underlies many diseases, including glioblastoma, neurofibromatosis, autism-spectrum disorders, and various neurodegenerative conditions, offering potential avenues for new treatments. The Hsp90 inhibitors it pursues are based on the radicicol scaffold, reflecting its focus on potent, selective agents. 

The company collaborates with experts in protein folding, kinase signaling, oncogenesis, and neurodegenerative disease, and maintains an expanding portfolio of related intellectual property. Positioned as a specialized, research-driven player in the pharmaceutical manufacturing landscape, NexGenix emphasizes scientific collaboration and rigorous discovery to advance its candidates.

Sign up for free to view info

Company overview Email format